Repurposing, Repositioning and Rescue of Drugs and Pharmaceuticals

Following on from our News Article of 6 April 2020 “Personalised Medicine Patents at the EPO”, regarding a case law summary of the patent protection available for existing pharmaceuticals in terms of dosing regimens and specific patient groups, we now look to explore repurposing, repositioning and rescue (DRPx) of existing drugs and pharmaceuticals.

Read More >